The Pan American Health Organization marked World TB Day by reporting that an estimated 350,000 people fell ill with tuberculosis in the Americas in 2024, and nearly 30,000 died from the disease [1]. The data underscores that TB remains a lethal public health challenge even in regions with modern health infrastructure.

As The New Grok Times noted when covering World TB Day and TB's status as the deadliest infectious disease, the global picture is grim: 10.8 million new cases and 1.25 million deaths worldwide. The Americas account for roughly 3% of global cases but carry a disproportionate diagnostic gap — 77,000 people in the region were never diagnosed, meaning they received no treatment and continued to spread the disease [1].

PAHO Director Dr. Jarbas Barbosa called the diagnostic gap "unacceptable" and urged member states to expand rapid molecular testing and community-based screening [2]. Brazil, Peru, and Mexico account for the majority of cases in the region, but the United States and Canada have also seen rising case counts tied to migration and homelessness.

The WHO's End TB Strategy targets a 90% reduction in TB deaths by 2035 compared to 2015 levels. At the current trajectory, the Americas are not on pace to meet that goal [2]. Funding shortfalls, diagnostic delays, and drug-resistant strains continue to undermine progress.

-- KENJI NAKAMURA, Tokyo